DUEXIS (Horizon Pharma Inc.)
Welcome to the PulseAid listing for the DUEXIS drug offered from Horizon Pharma Inc.. This Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Horizon Pharma Inc. |
| NON-PROPRIETARY NAME: | Ibuprofen and Famotidine |
| SUBSTANCE NAME: | IBUPROFEN; FAMOTIDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-04-29 |
| END MARKETING DATE: | 0000-00-00 |
DUEXIS HUMAN PRESCRIPTION DRUG Details:
| Item Description | DUEXIS from Horizon Pharma Inc. |
| LABELER NAME: | Horizon Pharma Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 800; 26.6(mg/1; mg/1) |
| START MARKETING DATE: | 2011-04-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 75987-010_74cc39f2-dea6-4f02-a0d5-8ec59538fcac |
| PRODUCT NDC: | 75987-010 |
| APPLICATION NUMBER: | NDA022519 |
Other IBUPROFEN; FAMOTIDINE Pharmaceutical Manufacturers / Labelers:
